Kuznetsov VA, Soldatova AM, Krinochkin DV, Enina TN

Slides:



Advertisements
Similar presentations
Presenter Disclosure Information
Advertisements

Cardiac Resynchronization Heart Failure Study Cardiac Resynchronization Heart Failure Study Presented at American College of Cardiology Scientific Sessions.
A Comparison of Early Versus Late Initiation of Renal Replacement Therapy in Critically III Patients with Acute Kidney Injury: A Systematic Review and.
Natale MARRAZZO Francesco SOLIMENE Quando la CRT-P può bastare?
Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy.
Update on Indications for Cardiac Resynchronization Therapy Maria Rosa Costanzo, M.D., F.A.C.C., F.A.H.A. Medical Director, Midwest Heart Specialists-Advocate.
Journal Review-CRT Dr Pradeep Sreekumar Senior Resident Cardiology.
Sudden Cardiac Death in Heart Failure Trial Presented at American College of Cardiology Scientific Sessions 2004 Presented by Dr. Gust H. Bardy SCD-HeFTSCD-HeFT.
Alon Barsheshet, MD1, Paul J. Wang, MD2, Arthur J. Moss, MD1, Scott D
May 23rd, 2012 Hot topics from the Heart Failure Congress in Belgrade.
The Latest Device Therapy in W. Herts Dr Philip Moore.
La selezione dei pazienti candidati alla Terapia Resincronizzante Cardiaca M Cristina Porciani Firenze “Incontri Pitagorici di Cardiologia 2010” “Πυθαγόρειοι.
Renal function and clinical outcomes of patients undergoing ICD and CRTD implantation- Data from the Israeli ICD Registry Alon Eisen, Mahmoud Souleiman,
Working Group of Heart Failure and Cardiac Function How to evaluate and treat dyssynchrony ? P Lancellotti, LA Piérard, Liège, BE.
May 2005 EP Show The EP Show COMPANION and CARE-HF Eric Prystowsky MD Director, Clinical Electrophysiology Laboratory St Vincent Hospital Indianapolis,
The Relationship Between Renal Function and Cardiac Structure, Function, and Prognosis Following Myocardial Infarction: The VALIANT Echo Study Anil Verma,
Presenter Disclosure Information John F. Beshai, MD RethinQ Trial Results Disclosures Information: The following relationships exist related to this presentation:
Target Study Cardiac resynchronization therapy (CRT) is an established treatment for advanced heart failure symptoms, impaired LV systolic function, and.
Results of the Predictors of Response to CRT (PROSPECT) Trial Chung ES, Leon AR, Tavazzi L, Sun J-P, Nihoyannopoulos P, Merlino J, Abraham WT, Ghio S,
All Rights Reserved, Duke Medicine 2008 Mechanical Dyssynchrony Defined by Phase Analysis from GSPECT: Does It Predict Mortality? Paul L. Hess, MD; Linda.
Date of download: 6/25/2016 Copyright © 2016 American Medical Association. All rights reserved. From: BNP-Guided vs Symptom-Guided Heart Failure Therapy:
METHODS The EASYTRAK 2 lead was studied along with the CONTAK  RENEWAL  2/4/4HE device in the Device Evaluation of the CONTAK RENEWAL 2/4/4HE with EASYTRAK.
Survival with Cardiac- Resynchronization Therapy in Mild Heart Failure.
Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Effect of Intermittent Atrial Tachyarrhythmia.
Date of download: 6/26/2016 From: Comparative Effectiveness of Cardiac Resynchronization Therapy With an Implantable Cardioverter- Defibrillator Versus.
Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Influence of Left Ventricular Ejection Fraction.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Tolerability and efficacy of carvedilol in patients.
Primary Mitral Regurgitation Degenerative Mitral Valve Disease
Date of download: 11/11/2016 Copyright © The American College of Cardiology. All rights reserved. From: Targeted Left Ventricular Lead Placement to Guide.
Total Occlusion Study of Canada (TOSCA-2) Trial
University Medical Center Groningen, The Netherlands
Copyright © 2011 American Medical Association. All rights reserved.
BLOCK HF Study Biventricular versus Right Ventricular Pacing in Patients with Left Ventricular Dysfunction and Atrioventricular Block – Preliminary Results.
Treatment options for patients with chronic symptomatic systolic heart failure. ACE, angiotensinconvertingenzyme; ARB, angiotensin receptor blocker; CRT-D,
Comparison of Low Versus High (>40 mm Hg) Pulse Pressure to Predict the Benefit of Cardiac Resynchronization Therapy for Heart Failure (from the Multicenter.
David M Kaye MD, PhD on behalf of the REDUCE LAP HF Investigators
These slides highlight a presentation at the Late Breaking Trial Session of the American College of Cardiology 52nd Annual Scientific Sessions in Chicago,
Treatment options for patients with chronic symptomatic systolic heart failure. ACE, angiotens inconverting enzyme; ARB, angiotensin receptor blocker;
Diminished Left Ventricular Dyssynchrony and Impact of Resynchronization in Failing Hearts With Right Versus Left Bundle Branch Block J Am Coll Cardiol.
– р<0.05 between baseline
Comparison of Outcomes of Patients With Left Ventricular Ejection Fractions ≤30% Versus ≥30% Having Transcatheter Aortic Valve Implantation (from the.
Prognostic significance of tumor subtypes in male breast cancer:
The Clinical Significance of Uric Acid and Complement Activation in the Progression of IgA Nephropathy Kidney Blood Press Res 2016;41: DOI: /
Background Methods Results Conclusion
Tyumen Cardiology Center, Russia Tyumen
The 28th Great Wall International Congress of Cardiology
Heart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations Cardiology 2015;132: DOI: / Fig. 1. Semilogarithmic.
Intensive Observation Unit Careggi University Hospital, Firenze Italy
EMPHASIS-HF Extended Follow-up
2) Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114
Canadian Cardiovascular Society Guidelines on the Use of Cardiac Resynchronization Therapy: Evidence and Patient Selection  Derek V. Exner, MD, MPH, David.
Erratum Heart Rhythm Volume 8, Issue 4, (April 2011)
European Heart Association Journal 2007 April
MASTER Trial Inclusion Criteria
Study Design Patients with LBBB and LV dysfunction
Sustained Benefits of the CorCap Cardiac Support Device on Left Ventricular Remodeling: Three Year Follow-up Results From the Acorn Clinical Trial  Randall.
Angelo Auricchio, and Frits W. Prinzen JACEP 2017;3:
Mirnela Byku, and Douglas L. Mann BTS 2016;1:95-106
Mortality Data From the BASKET LATE Trial and PREMIER Registry
Impact of Platelet Reactivity Following Clopidogrel Administration
Volume 14, Issue 12, Pages (December 2017)
Volume 15, Issue 1, Pages (January 2018)
Angelo Auricchio, and Frits W. Prinzen JACEP 2017;j.jacep
Understanding the cardiac substrate and the underlying physiology: Implications for individualized treatment algorithm  John Gorcsan, MD, Frits W. Prinzen,
Emilce Trucco et al. JACEP 2018;j.jacep
Venn diagram of patients with paired pre-cardiac resynchronisation therapy (CRT) and post-CRT echocardiograms. Venn diagram of patients with paired pre-cardiac.
Dynamic cardiomyoplasty: at the crossroads
Recurrent Vascular Access Dysfunction as a Novel Marker of Cardiovascular Outcome and Mortality in Hemodialysis Patients Kim et al. Am J Nephrol 2016;44:71-80.
A. Procopi, N. Procopi, JP Collet, O. Barthelemy, P. Leprince, R
Presentation transcript:

Kuznetsov VA, Soldatova AM, Krinochkin DV, Enina TN Tyumen Cardiology Research Center www.infarkta.net 625026 Tyumen, Melnikaite 111 Dynamics of left ventricular volumes and mortality in patients with early and late effect of cardiac resynchronization therapy Kuznetsov VA, Soldatova AM, Krinochkin DV, Enina TN Background Results Response to cardiac resynchronisation therapy (CRT) can be relatively «early» and «late» but the relationship between time of the best response and long-term mortality still remains unclear. Groups did not differ in clinical characteristics, NYHA functional class, QRS duration and parameters of mechanical dyssynchrony. During follow-up period (34.9±16.1 months) increase in LVEF (p=0.004) and decrease in LVESV (p<0.001) were more evident in patients with «late» response. Responders Aim To analyze the relationship between echocardiographic parameters, time of the best response and mortality in patients with congestive heart failure (CHF). Materials and methods In Kaplan-Meier analysis mortality in II group was significantly lower (3.8% vs 26.9%; p=0.001). Cox regression showed that LVESV (HR 1.014; 95% CI 1.005–1.024; p=0.002) and the time of response (HR 0.176; 95% CI 0.041–0.751 p=0.019) were associated with long-term mortality. 106 patients (83% men, III-IV NYHA), mean age 54.7 ± 9.9 years p˂0.001 At baseline, 1, 3 months and each 6 months after implantation we evaluated clinical and echocardiographic parameters The best decrease of LVESV was achieved up to 3 months I group – «early» response (1.2±0.9 months; n=26) The best decrease of LVESV was achieved after 3 months II group – «late» response (22.2±14.7 months; n=80) «late» response «early» response mortality . LVESV – left ventricular end-systolic volume. Fig. 2. Survival in patients with «early» and «late» response to CRT. Discussion According to some data one of the fundamental mechanisms of CRT is elimination of electrical dyssynchrony. It was shown that patients with wide QRS complex and the presence of left bundle branch block (LBBB) demonstrate better dynamics of clinical, functional parameters and better increase of LVEF. According to other studies the positive effects of CRT are related to the elimination of mechanical dyssynchrony parameters assessed by echocardiography. In our study patients with different time of the best response to the CRT didn’t differ in width of the QRS complex and the presence of LBBB. Also groups didn’t differ in mechanical dyssynchrony parameters. Obviously there is no single mechanism that causes the positive effect of CRT and it can be quite different in even in comparable groups. Decrease of LVESV ≥ 15% used as a standardised criteria of CRT response, however, there is still no single opinion in what observation period it should be assessed. Most studies assess echocardiographic changes during the first year after implantation. In our study 2/3 patients showed best dynamics of LVESV and LVEF in long-term period and these changes were significantly more pronounced than in patients who had the best response to the CRT during the first three months. It should be noted that 60% of responders with «late» response didn’t have positive dynamics of LVESV and LVEF during the first year of observation. The psychological aspect of our results is very important. Physicians and patients wait for a quick response to CRT and functional improvement even during the first days. It seems that fast response is associated with better reaction to CRT. Our study demonstrated association of long-term survival and time of the best response and reverse remodeling after CRT. It is important that the «early» response was associated with less clinical and functional changes and worse survival in the long term follow-up. Thus «early» clinical and functional improvement can not be used as a marker of the efficacy of CRT in the context of long-term mortality. . Conclusion Patients with «early» response to CRT show significantly lower improvement in LVEF and LVESV compared to patients with «late» CRT response. «Early» response and greater LVESV are associated with higher mortality rate.   The authors have nothing to disclose.